首页制药产品大全药品制剂血液系统类制剂 Iron & Folic Acid Duo: Boosting Anemia Recovery

Iron & Folic Acid Duo: Boosting Anemia Recovery

更新时间：2025-06-18

价格： 7 元/个

地区：上海市

是否提供样品：否

立即询盘

产品详情

产品名称： Iron & Folic Acid Duo: Boosting Anemia Recovery

产品分类：血液系统药制剂

产品关键词： Ferrous Sulfate and Folic Acid Combination,Anemia Treatment,Iron and Folate Supplement,Dual-Action Anemia Support,Iron Deficiency and Folic Acid Deficiency Management

是否为生产商：是

主要销售市场：中国,北美洲,中/南美洲,西欧,大洋洲,亚洲,中东

是否提供样品：否

产品描述：

Mechanism of Action

Ferrous sulfate and folic acid are essential components in the treatment of various types of anemia. Ferrous sulfate works by replacing depleted iron stores in hemoglobin, myoglobin, and enzymes, facilitating the transportation of oxygen via hemoglobin. It is crucial for effective erythropoiesis (red blood cell production) and serves as a cofactor for several essential enzymes, including cytochromes involved in electron transport.

Folic acid, on the other hand, is necessary for nucleoprotein synthesis and the maintenance of normal erythropoiesis. It is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase (DHFR). Tetrahydrofolic acid acts as a coenzyme in various metabolic processes, including the synthesis of purines and thymidylate nucleic acids, interconversion of amino acids, methylation of tRNA, and the generation and utilization of formate. Folic acid also helps normalize high homocysteine levels by remethylating homocysteine to methionine via methionine synthetase.

Applications

The combination of ferrous sulfate and folic acid is primarily used to treat and prevent iron deficiency anemia and folate deficiency anemia. It is particularly effective in addressing anemia during pregnancy, where both iron and folate requirements increase. This combination is also used to prevent neural tube defects in pregnant women and to manage megaloblastic anemia caused by folate deficiency. Additionally, it is used as a nutritional supplement for women of childbearing potential and in cases of methotrexate toxicity.

Future Prospects

The future outlook for the combination of ferrous sulfate and folic acid is promising, given the increasing awareness of nutritional deficiencies and their impact on health. Ongoing research is focusing on optimizing the formulation to improve absorption and reduce gastrointestinal side effects. The growing emphasis on prenatal care and the prevention of birth defects further underscores the importance of this combination in public health initiatives.

Dosage and Administration

Adults:

Iron Deficiency Anemia: The typical dose is one tablet containing 200 mg of ferrous sulfate and 0.4 mg of folic acid, taken once daily on an empty stomach, at least 1 hour before or 2 hours after a meal.
Pregnancy: The same dosage is recommended for pregnant women to prevent anemia and neural tube defects.
Children:
The dosage may vary depending on the child's age and weight, but it is generally lower than that for adults. It should be adjusted according to the pediatrician's advice.
Special Instructions:
Ferrous sulfate and folic acid should be taken on an empty stomach for maximum absorption, but it can be taken with food to minimize gastrointestinal irritation.
Avoid taking antacids or antibiotics within 2 hours before or after taking this combination, as they may interfere with absorption.

Storage

Ferrous sulfate and folic acid tablets should be stored in a cool, dry place, protected from light and moisture. The container should be tightly closed to prevent exposure to air. It is crucial to keep the medication out of reach of children to prevent accidental ingestion, which can lead to severe iron poisoning.

公司简介

上海浦津林州制药有限公司，始建于1974年，其前身是林州市市属工业企业--安阳市化学制药厂， 2015年9月更名为“上海浦津林州制药有限公司” 公司位于风景秀丽的太行山东麓，举世闻名的人工天河——红旗渠畔，交通便利，通讯发达。公司占地面积5.5万m2，建筑面积1.9万m2，其中仓储面积3000 m2；厂区绿化面积16000 m2，硬化面积8000 m2。现有职工300余人，固定资产总值6418万元，主导产品主要有葡萄糖酸钙、硫酸镁、维生素C、肌苷等35个注射液品种，在市场上深受广大客户青睐，市场前景广阔。公司为了进一步扩大生产规模，提升产品档次，提高市场占有率，先后投资3.6亿余元，进行技术改造，现在拥有12条符合国家GMP标准的小容量注射剂全自动生产线，并于2014年5月通过国家食品药品监督管理局GMP认证；新建车间年设计生产能力12亿支，可实现产值3亿多元，利税5000余万元。近年来，公司创新意识不断增强，始终把“技术创新，科技兴厂”作为公司发展的宗旨，企业发展空间大、前景广阔，愿各界同仁、有识之士携手并进，共谋美好未来。

该公司其他产品

Insulin Pen: Precision and Convenience for Diabetes Management

Mechanism of ActionInsulin pens are designed to deliver insulin directly into the subcutaneous tissue. They combine the insulin cartridge and a syringe into a single, portable device. The pen allows for precise dosing and administration, ensuring that the exact amount of insulin is delivered each time. This mechanism helps in better glucose control by providing accurate and consistent insulin doses.BenefitsConvenience: Insulin pens are compact, portable, and easy to use, making them ideal for on-the-go insulin administration.Accuracy: They offer precise dosage adjustments, reducing the risk of dosing errors compared to traditional syringes and vials.Discreetness: The design allows for discreet use in public settings.Reduced Pain: Insulin pens typically use fine needles, resulting in less pain and discomfort during injections.Improved Compliance: The ease of use and accuracy can enhance patient adherence to their insulin regimen.Usage InstructionsPreparation: Wash your hands thoroughly. Attach a new pen needle to the insulin pen.Priming: Prime the pen by dialing a small dose and expelling it into the air until a droplet forms at the needle tip. This step ensures there are no air bubbles in the pen.Dose Selection: Dial the prescribed insulin dose using the pen’s dose selector.Injection: Pinch the skin at the injection site (commonly the abdomen or thigh) and insert the needle at a 90-degree angle. Press the plunger fully to administer the insulin.Post-Injection: Remove the needle and dispose of it safely. Recap the pen for storage.StorageUnopened Pens: Store insulin pens in the refrigerator at 2°C to 8°C (36°F to 46°F) until they are ready to be used.Opened Pens: Once started, pens can be stored at room temperature (not exceeding 30°C/86°F) for up to 28 days.Protection from Temperature Extremes: Avoid exposing the pen to extreme temperatures, as this can damage the insulin.

Artemether: Potent Antimalarial for Malaria Management

Mechanism of ActionArtemether is a derivative of artemisinin, a natural compound derived from the plant Artemisia annua. It exerts its antimalarial effects primarily through the following mechanisms:Generation of Free Radicals: Artemether contains an endoperoxide bridge that is cleaved in the presence of heme (a byproduct of hemoglobin digestion by the malaria parasite). This process generates highly reactive free radicals, which damage the parasite's cell membranes and disrupt its essential cellular functions.Inhibition of Parasite Enzymes: Artemether inhibits an essential calcium ATPase (PfATP6) in the malaria parasite, leading to intracellular calcium accumulation and subsequent cell death.Disruption of Hemoglobin Detoxification: Artemether interferes with the parasite's ability to detoxify heme, which is produced during hemoglobin digestion. This leads to the accumulation of toxic substances within the parasite, ultimately causing its death.Inhibition of Nucleic Acid and Protein Synthesis: Artemether and its active metabolite, dihydroartemisinin, inhibit the synthesis of nucleic acids and proteins in the malaria parasite, further contributing to its antimalarial activity.ApplicationsArtemether is primarily used for the treatment of malaria caused by Plasmodium falciparum, including:Uncomplicated Malaria: Artemether is effective against uncomplicated malaria infections, particularly in regions where chloroquine resistance is prevalent.Severe Malaria: Although artemether can be used for severe malaria, intramuscular artemether is less reliable than other artemisinin derivatives like artesunate due to its poor water solubility and variable absorption.Multidrug-Resistant Malaria: Artemether is often used in combination with other antimalarial drugs (e.g., lumefantrine) to treat malaria that is resistant to multiple drugs.Dosage and AdministrationAdults:Oral/Intramuscular: 80 mg twice daily on the first day, followed by 80 mg once daily for the next 4 days. The maximum total dose is 480 mg over 5 days.Children:Intramuscular: 3.2 mg/kg body weight on the first day, followed by 1.6 mg/kg once daily for the next 4 days. The maximum total dose is 9.6 mg/kg over 5 days.Combination Therapy: When used in combination with lumefantrine, the dosing schedule may vary depending on the specific formulation and patient weight.Example for Artemether-Lumefantrine Combination:Children (5-15 kg): 1 tablet at diagnosis, 1 tablet after 8 hours, then 1 tablet twice daily for the next 2 days.Children (15-25 kg): 2 tablets at diagnosis, 2 tablets after 8 hours, then 2 tablets twice daily for the next 2 days.Adults and Children (≥35 kg): 4 tablets at diagnosis, 4 tablets after 8 hours, then 4 tablets twice daily for the next 2 days.StorageConditions: Artemether should be stored in a cool, dry place, protected from light and moisture. It is typically stable at room temperature (15-30°C) but should be kept out of reach of children.Expiration: Always check the expiration date on the product packaging. Do not use expired medication.

Furosemide : Effective Loop Diuretic for Heart Failure and Hypertension

Mechanism of ActionFurosemide is a potent loop diuretic that primarily works by inhibiting the Na+/K+/2Cl⁻ co-transporter (NKCC2) in the thick ascending limb of the loop of Henle in the kidneys. By blocking this transporter, furosemide reduces the reabsorption of sodium, potassium, and chloride ions. This leads to an increase in the osmolarity of the tubular fluid, resulting in greater water retention in the renal tubules and ultimately increased urine output. Additionally, furosemide can increase the synthesis of prostaglandin E2 (PGE2), which helps to dilate renal blood vessels, enhance renal blood flow, and increase glomerular filtration rate.ApplicationsEdema Management: Furosemide is used to treat edema associated with various conditions such as heart failure, cirrhosis (e.g., ascites), and nephrotic syndrome.Hypertension Management: It reduces blood pressure by decreasing blood volume through diuresis.Acute Pulmonary Edema: Furosemide can rapidly alleviate symptoms of acute pulmonary edema.Hyperkalemia: It helps lower serum potassium levels by promoting potassium excretion.Dosage and AdministrationOral Administration:Adults: The initial dose is typically 20–80 mg once or twice daily.Children: The dose is usually calculated based on body weight, at 1–2 mg/kg once or twice daily.Onset of Action: Oral administration typically results in diuresis within 30–60 minutes, with peak effects occurring within 1–2 hours.Duration of Action: The diuretic effect lasts for approximately 6–8 hours.Intravenous (IV) Administration:Adults: The initial dose is usually 20–40 mg, which may be repeated if necessary.Children: The dose is 1–2 mg/kg, which may be repeated if necessary.Onset of Action: IV administration results in diuresis within 5 minutes, with peak effects occurring within 30 minutes.Duration of Action: The diuretic effect lasts for approximately 2 hours.Precautions: When using furosemide, it is essential to closely monitor electrolyte levels to avoid electrolyte disturbances caused by excessive diuresis.StorageStorage Conditions: Furosemide tablets should be stored in a dry, cool place, protected from high temperatures and direct sunlight.Expiration Date: Always refer to the expiration date on the product packaging. Do not use expired medication.Child Safety: Ensure that the medication is stored out of reach of children.

产品名称	价格	供应商	操作
Iron chloride hexahydrate CAS 10025-77-1	面议	上海领航智业化工有限公司	立即询盘
Iron dextran	2-6	湖南艾臣科技集团股份有限公司	立即询盘
IRON DEXTRAN	面议	广西药物研究所兽药厂	立即询盘
Iron Dextran and Vitamin B12 injection	面议	石家庄石牧药业有限公司	立即询盘
Iron Dextran Inj	面议	杭州浦萝施特进出口有限公司	立即询盘
Iron Dextran Inj. 100mg/2ml,250mg/5ml	面议	杭州兆隆丰生物医药有限公司	立即询盘
Iron Dextran Injetion	面议	内蒙古中晖药业有限公司	立即询盘
Iron Dextran Powder 38%	面议	广西农大康园生物药品有限公司	立即询盘
Iron sucrose injection	面议	上海卡扩进出口有限公司	立即询盘
Iron Sucrose Injection 100mg/5ml	面议	南京三诺医药科技有限公司	立即询盘